24782-66-9

Upstream product

• 98370-26-4 2-N-(2-methylphenyl) aminoisophthalic acid 
• 80841-45-8 2-<(2-carboxyphenyl)amino>-3-methylbenzoic acid 
• 59425-36-4 3-methylanthranilic acid potassium salt 
• 118-91-2 ortho-chlorobenzoic acid 
• 2902-65-0 2-iodoyl-1,3-benzenedicarboxylic acid 
• 95-53-4 o-toluidine 
• 4389-45-1 3-methylantranilic acid 
• 39622-79-2 2-aminoisophthalic acid 

Downstream Products

• 106626-72-6 5-Methyl-acridine-4-carboxylic acid (2-dimethylamino-ethyl)-amide 
• 89459-51-8 9-Amino-5-methyl-acridine-4-carboxylic acid (2-dimethylamino-ethyl)-amide 
• 92138-16-4 9-(4-Methanesulfonylamino-2-methoxy-phenylamino)-5-methyl-acridine-4-carboxylic acid methylamide; hydrochloride 

Relevant academic research and scientific papers

Anticancer anilinoacridines. A process synthesis of the disubstituted amsacrine analog CI-921

An improved process for the synthesis of bulk quantities of the clinical amsacrine analog CI-921 is reported. Described also are detailed analytical and spectroscopic data for this agent.

Potential Antitumor Agents. 46. Structure-Activity Relationships for Acridine Monosubstituted Derivatives of the Antitumor Agent N--9-aminoacridine-4-carboxamide

A series of monosubstituted derivatives of the new antitumor agent N--9-aminoacridine-4-carboxamide has been prepared, bearing methyl, methoxy, and chloro groups at available acridine positions.The physicochemical properties and an

Potential antitumor agents. 40. Orally active 4,5-disubstituted derivatives of amsacrine

The DNA-intercalating agent amsacrine is an effective drug for the treatment of human leukemias and lymphomas but has minimal solid tumor activity. As a first step in identifying analogues with a wider spectrum of activity, a comparison was made of the in

Compound having antitumor properties

The compound 4'-(9-[4-[N-methyl-carboxamido]-5-methyl]acridinylamino)methanesulphon-m-anisidide and acid addition salts thereof have antitumor properties.